Mergers & acquisitions
Mergers & acquisitions
Greater than the sum of its parts
Milliman M&A solutions
Post-deal integration
Advanced modelling
Milliman M&A insight
Non-Life Part VII Transfers: A Dwindling Trend?
We’re set to see in 2023 the fewest non-life Part VII transfers sanctioned by the UK since the early 2000s. What does the future hold for the strategy?
Global Life and Health Insurance M&A in 2022 and beyond
In 2022, life and health insurance transaction activity was down sharply. Our research points to the likely causes and projects the landscape for future mergers and acquisitions.
Getting the best from buy-side opportunities
Success in mergers and acquisitions (M&A) often requires the potential acquirer to identify opportunities to increase the value of the target.
Life and Health Insurance M&A in 2021 and beyond
We review the M&A worldwide for life and health insurers in 2021, and an outlook for 2022 and beyond.
Transactions, transfers and restructurings
Topics include an update on Part VII transfers and schemes of arrangement and an update on M&A activity in Europe.
For M&A professionals, quantifying cyber risk is key
A significant benefit of a cyber risk assessment during M&A due diligence is that it presents the broadest view of how to value the cyber risk of a target company, while at the same time taking into account that company's current insurance protections.
Shining new light on European insurance M&A
In this article, we illustrate the sorts of analyses which are possible by looking at a sample of 24 transactions in Europe over the last couple of years across a wide range of EU markets.
A valuation methodology for M&A transactions
The Solvency II Appraisal Value (SII-AV) provides a workable methodology for use in M&A transactions, which is aligned with the way that investors generally view potential target companies.
